Liss Per, Hansell Peter, Fasching Angelica, Palm Fredrik
a Department of Oncology, Radiology and Clinical Immunology, Section of Radiology , University Hospital , Uppsala , Sweden ;
b Department of Medical Cell Biology, Section of Integrative Physiology , Uppsala University , Uppsala , Sweden ;
Ups J Med Sci. 2016;121(1):12-6. doi: 10.3109/03009734.2016.1144664. Epub 2016 Mar 2.
Objectives Mechanisms underlying contrast medium (CM)-induced nephropathy remain elusive, but recent attention has been directed to oxygen availability. The purpose of this study was to evaluate the effect of the low-osmolar CM iopromide and the iso-osmolar CM iodixanol on oxygen consumption (QO2) in freshly isolated proximal tubular cells (PTC) from kidneys ablated from elderly humans undergoing nephrectomy for renal carcinomas and from normoglycemic or streptozotocin-diabetic rats. Materials PTC were isolated from human kidneys, or kidneys of normoglycemic or streptozotocin-diabetic rats. QO2 was measured with Clark-type microelectrodes in a gas-tight chamber with and without each CM (10 mg I/mL medium). L-NAME was used to inhibit nitric oxide (NO) production caused by nitric oxide synthase. Results Both CM reduced QO2 in human PTC (about -35%) which was prevented by L-NAME. PTC from normoglycemic rats were unaffected by iopromide, whereas iodixanol decreased QO2 (-34%). Both CM decreased QO2 in PTC from diabetic rats (-38% and -36%, respectively). L-NAME only prevented the effect of iopromide in the diabetic rat PTC. Conclusions These observations demonstrate that CM can induce NO release from isolated PTC in vitro, which affects QO2. Our results suggest that the induction of NO release and subsequent effect on the cellular oxygen metabolism are dependent on several factors, including CM type and pre-existing risk factors for the development of CM-induced nephropathy.
目的 造影剂(CM)诱发肾病的潜在机制仍不清楚,但最近人们的注意力已转向氧供应情况。本研究的目的是评估低渗性CM碘普罗胺和等渗性CM碘克沙醇对从因肾癌接受肾切除术的老年人切除的肾脏以及正常血糖或链脲佐菌素诱导糖尿病大鼠切除的肾脏中新鲜分离的近端肾小管细胞(PTC)氧消耗(QO2)的影响。材料 从人肾或正常血糖或链脲佐菌素诱导糖尿病大鼠的肾脏中分离PTC。在有和没有每种CM(10 mg I/mL培养基)的气密小室中,用Clark型微电极测量QO2。L-精氨酸甲酯(L-NAME)用于抑制一氧化氮合酶产生的一氧化氮(NO)。结果 两种CM均降低了人PTC中的QO2(约-35%),L-NAME可防止这种降低。正常血糖大鼠的PTC不受碘普罗胺影响,而碘克沙醇降低了QO2(-34%)。两种CM均降低了糖尿病大鼠PTC中的QO2(分别为-38%和-36%)。L-NAME仅防止了碘普罗胺对糖尿病大鼠PTC的作用。结论 这些观察结果表明,CM在体外可诱导分离的PTC释放NO,这会影响QO2。我们的结果表明,NO释放的诱导及其对细胞氧代谢的后续影响取决于几个因素,包括CM类型和CM诱发肾病发生的预先存在的危险因素。